Gene · 8115
Papers1,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,926
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia. | Oncoimmunology | 2023 | 37937211 | PubTator, text mining | PubMed |
| Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis. | Nat Genet | 2023 | 37932435 | PubTator, text mining | PubMed |
| Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation. | Front Endocrinol (Lausanne) | 2023 | 37929027 | PubTator, text mining | PubMed |
| Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis. | Front Immunol | 2023 | 37908350 | PubTator, text mining | PubMed |
| Cell-type-specific molecular characterization of cells from circulation and kidney in IgA nephropathy with nephrotic syndrome. | Front Immunol | 2023 | 37908345 | PubTator, text mining | PubMed |
| Determinants of mosaic chromosomal alteration fitness. | medRxiv | 2023 | 37905118 | PubTator, text mining | PubMed |
| Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis. | Case Rep Oncol | 2023 | 37900812 | PubTator, text mining | PubMed |
| Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report. | Case Rep Oncol | 2023 | 37900793 | PubTator, text mining | PubMed |
| T Lymphoblastic Lymphoma Hiding in Mature Plasmacytoid Dendritic Cell Proliferation: A Case Report and Literature Review. | Diagnostics (Basel) | 2023 | 37892069 | PubTator, text mining | PubMed |
| Recurrent Chemotherapy Treated Indeterminate Dendritic Cell Tumor: Case Report and Literature Review. | Clin Cosmet Investig Dermatol | 2023 | 37881204 | PubTator, text mining | PubMed |
| Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia. | Nat Commun | 2023 | 37880218 | PubTator, text mining | PubMed |
| Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case. | J Community Hosp Intern Med Perspect | 2023 | 37868236 | PubTator, text mining | PubMed |
| Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability. | Front Immunol | 2023 | 37849750 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility and transcriptomic characterization of Behcet's disease. | Commun Biol | 2023 | 37848613 | PubTator, text mining | PubMed |
| Integration of scRNA-Seq and bulk RNA-Seq uncover perturbed immune cell types and pathways of Kawasaki disease. | Front Immunol | 2023 | 37841239 | PubTator, text mining | PubMed |
| Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling. | Cancers (Basel) | 2023 | 37835430 | PubTator, text mining | PubMed |
| Progress of research on PD-1/PD-L1 in leukemia. | Front Immunol | 2023 | 37822924 | PubTator, text mining | PubMed |
| Beyond Human Limits: Harnessing Artificial Intelligence to Optimize Immunosuppression in Kidney Transplantation. | J Clin Med Res | 2023 | 37822851 | PubTator, text mining | PubMed |
| Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia. | Exp Hematol Oncol | 2023 | 37817276 | PubTator, text mining | PubMed |
| Mosaic loss of the Y chromosome in human neurodegenerative and oncological diseases. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37808213 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8115/papers?page=9